수의용 바이오마커 시장 보고서(2026년)

Veterinary biomarkers are measurable indicators used to diagnose, monitor, and manage diseases in animals. These can include biological molecules such as proteins, genes, or metabolites that reflect a specific physiological or pathological state. Veterinary biomarkers are essential for early disease detection, evaluating treatment efficacy, and understanding disease mechanisms.

The primary types of veterinary biomarkers include biomarkers themselves, kits and reagents, and biomarker readers. Biomarkers are specific biological molecules or substances used to detect, diagnose, and monitor health conditions in animals. These biomarkers, present in blood, urine, or other body fluids, provide important insights into an animal's health status. They are used for various diseases, including inflammatory and infectious diseases, cardiovascular diseases, skeletal muscle diseases, tumors, and more. Applications of these biomarkers span disease diagnostics, preclinical research, and other areas, affecting both companion and production animals.

Tariffs have affected the veterinary biomarkers market by raising costs for imported kits, reagents, and biomarker readers. Segments such as ELISA kits, PCR kits, and optical or fluorescence readers are most impacted, particularly in North America and Europe. While tariffs increase operational costs, they encourage local manufacturing, promote innovation in cost-effective biomarker solutions, and accelerate the adoption of domestic diagnostic technologies.

The veterinary biomarkers market research report is one of a series of new reports from The Business Research Company that provides veterinary biomarkers market statistics, including veterinary biomarkers industry global market size, regional shares, competitors with a veterinary biomarkers market share, detailed veterinary biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary biomarkers industry. This veterinary biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary biomarkers market size has grown rapidly in recent years. It will grow from $0.91 billion in 2025 to $1.02 billion in 2026 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to reliance on conventional diagnostics, limited biomarker availability, growing prevalence of animal diseases, traditional veterinary research methods, low adoption of preclinical research tools.

The veterinary biomarkers market size is expected to see rapid growth in the next few years. It will grow to $1.61 billion in 2030 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to advancement in biomarker discovery, increasing investment in veterinary diagnostics, rising awareness of animal health monitoring, growth of companion and production animal segments, adoption of automated biomarker readers and digital platforms. Major trends in the forecast period include expansion of diagnostic biomarker development, growth in predictive and prognostic biomarker applications, increasing adoption of elisa, pcr, and rapid test kits, rising use of advanced biomarker readers and analytical devices, growing focus on companion and production animal health.

The rising pet ownership is expected to drive the growth of the veterinary biomarkers market going forward. Pet ownership refers to the state of having one or more animals as companions, where individuals provide care, shelter, and attention to meet their pets' needs and well-being. The increase in pet ownership is attributed to factors such as the desire for companionship, the benefits of pet therapy, and growing awareness of the positive impact pets have on mental and physical health. Veterinary biomarkers support pet ownership by monitoring animal health, enabling early disease detection, and facilitating personalized treatment plans. For example, in June 2025, according to Petfood Industry, a US-based leading resource for pet food and treat manufacturers, 94 million U.S. households owned at least one pet, up from 82 million in 2023, reflecting a significant rise in pet ownership and growing demand for pet care products and services. Therefore, the increase in pet ownership is driving the growth of the veterinary biomarkers market.

Leading players in the veterinary biomarkers market are focusing on strategic partnerships to strengthen their competitive position. Strategic partnerships involve collaborations among companies, research institutions, and veterinary practices to advance the development and application of diagnostic tools. For example, in November 2025, Bionote USA, a US-based veterinary diagnostics company, launched the Vcheck C1 In-Clinic Chemistry Analyzer, an affordable and compact biochemistry testing device designed to expand point-of-care biomarker and diagnostic capabilities in veterinary practices. The Vcheck C1 enables simultaneous analysis of up to 24 biochemical parameters from small animal samples in 10-12 minutes, delivering laboratory-grade accuracy with a simplified workflow. It supports testing across 34 species, including canine, feline, equine, and bovine patients, with validated reference ranges for each species. Featuring broad test panels such as comprehensive chemistry, electrolyte, liver, kidney, and diabetes profiles, the analyzer helps clinicians quickly diagnose and monitor health conditions without sending samples to external laboratories. Its affordable pricing and multi-species support enhance access to rapid, in-clinic biomarker diagnostics across a wide range of veterinary settings.

In November 2025, Zoetis Inc., a US-based provider of animal health medicines, vaccines, diagnostics, and technology solutions, acquired Veterinary Pathology Group (VPG) for an undisclosed amount. Through this acquisition, Zoetis aimed to expand its veterinary diagnostics portfolio, enhancing its ability to provide advanced biomarker and pathology testing solutions to veterinarians in the UK and Ireland while strengthening its global diagnostic footprint. Veterinary Pathology Group is a UK- and Ireland-based provider of comprehensive laboratory diagnostic services supporting biomarker-based testing for disease detection and monitoring in animal health.

Major companies operating in the veterinary biomarkers market are Thermo Fisher Scientific Inc., Zoetis Inc., IDEXX Laboratories Inc., Antech Diagnostics Inc., Neogen Corporation, Heska Corporation, Olink Proteomics, SomaLogic, Life Diagnostics Inc., INDICAL BIOSCIENCE GmbH., Mercodia AB, Bionote USA Inc., Acuvet Biotech, Alertix Veterinary Diagnostics AB., MI:RNA Diagnostics Ltd., Veterinary Biomarkers Inc., Vetmaya Healthcare Private Limited, VolitionRx, BioVet Diagnostics, Randox Laboratories Ltd., Bio-Rad Laboratories Inc., QIAGEN N.V., FidoCure, Scil Animal Care Company GmbH, Shenzhen Mindray Animal Medical Technology Co. Ltd., Esaote SPA, Innovative Diagnostics SAS, Ayoxxa Biosystems

North America was the largest region in the veterinary biomarkers market in 2025. The regions covered in the veterinary biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The veterinary biomarkers market consists of sales of biomarker research tools, imaging biomarkers, diagnostic kits, and immunoassays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Biomarkers Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses veterinary biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary biomarkers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary biomarkers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Biomarkers; Kits And Reagents; Biomarker Readers
• 2) By Disease Type: Inflammatory And Infectious Diseases; Cardiovascular Diseases; Skeletal Muscle Diseases; Tumor; Other Disease Types
• 3) By Animal Type: Companion Animals; Production Animals
• 4) By Application: Disease Diagnostics; Preclinical Research; Other Applications
• Subsegments:
• 1) By Biomarkers: Diagnostic Biomarkers; Prognostic Biomarkers; Predictive Biomarkers; Pharmacodynamic Biomarkers
• 2) By Kits And Reagents: ELISA Kits; PCR Kits; Western Blotting Kits; Rapid Test Kits; Reagents For Biomarker Detection
• 3) By Biomarker Readers: Optical Readers; Fluorescence Readers; Luminometers; Real-Time PCR Machines; Microplate Readers
• Companies Mentioned: Thermo Fisher Scientific Inc.; Zoetis Inc.; IDEXX Laboratories Inc.; Antech Diagnostics Inc.; Neogen Corporation; Heska Corporation; Olink Proteomics; SomaLogic; Life Diagnostics Inc.; INDICAL BIOSCIENCE GmbH.; Mercodia AB; Bionote USA Inc.; Acuvet Biotech; Alertix Veterinary Diagnostics AB.; MI:RNA Diagnostics Ltd.; Veterinary Biomarkers Inc.; Vetmaya Healthcare Private Limited; VolitionRx; BioVet Diagnostics; Randox Laboratories Ltd.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; FidoCure; Scil Animal Care Company GmbH; Shenzhen Mindray Animal Medical Technology Co. Ltd.; Esaote SPA; Innovative Diagnostics SAS; Ayoxxa Biosystems
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Veterinary Biomarkers Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Veterinary Biomarkers Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Veterinary Biomarkers Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Veterinary Biomarkers Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.4 Biotechnology, Genomics & Precision Medicine
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Expansion Of Diagnostic Biomarker Development
  • 4.2.2 Growth In Predictive And Prognostic Biomarker Applications
  • 4.2.3 Increasing Adoption Of Elisa, Pcr, And Rapid Test Kits
  • 4.2.4 Rising Use Of Advanced Biomarker Readers And Analytical Devices
  • 4.2.5 Growing Focus On Companion And Production Animal Health

5. Veterinary Biomarkers Market Analysis Of End Use Industries

• 5.1 Veterinary Hospitals And Clinics
• 5.2 Diagnostic Laboratories
• 5.3 Research Institutes
• 5.4 Preclinical Research Organizations
• 5.5 Animal Health Service Providers

6. Veterinary Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Veterinary Biomarkers Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Veterinary Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Veterinary Biomarkers Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Veterinary Biomarkers Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Veterinary Biomarkers Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Veterinary Biomarkers Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Veterinary Biomarkers Market Segmentation

• 9.1. Global Veterinary Biomarkers Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Biomarkers, Kits And Reagents, Biomarker Readers
• 9.2. Global Veterinary Biomarkers Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Inflammatory And Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Other Disease Types
• 9.3. Global Veterinary Biomarkers Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Companion Animals, Production Animals
• 9.4. Global Veterinary Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Disease Diagnostics, Preclinical Research, Other Applications
• 9.5. Global Veterinary Biomarkers Market, Sub-Segmentation Of Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diagnostic Biomarkers, Prognostic Biomarkers, Predictive Biomarkers, Pharmacodynamic Biomarkers
• 9.6. Global Veterinary Biomarkers Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• ELISA Kits, PCR Kits, Western Blotting Kits, Rapid Test Kits, Reagents For Biomarker Detection
• 9.7. Global Veterinary Biomarkers Market, Sub-Segmentation Of Biomarker Readers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Optical Readers, Fluorescence Readers, Luminometers, Real-Time PCR Machines, Microplate Readers

10. Veterinary Biomarkers Market Regional And Country Analysis

• 10.1. Global Veterinary Biomarkers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Veterinary Biomarkers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Veterinary Biomarkers Market

• 11.1. Asia-Pacific Veterinary Biomarkers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Veterinary Biomarkers Market

• 12.1. China Veterinary Biomarkers Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Veterinary Biomarkers Market

• 13.1. India Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Veterinary Biomarkers Market

• 14.1. Japan Veterinary Biomarkers Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Veterinary Biomarkers Market

• 15.1. Australia Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Veterinary Biomarkers Market

• 16.1. Indonesia Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Veterinary Biomarkers Market

• 17.1. South Korea Veterinary Biomarkers Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Veterinary Biomarkers Market

• 18.1. Taiwan Veterinary Biomarkers Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Veterinary Biomarkers Market

• 19.1. South East Asia Veterinary Biomarkers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Veterinary Biomarkers Market

• 20.1. Western Europe Veterinary Biomarkers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Veterinary Biomarkers Market

• 21.1. UK Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Veterinary Biomarkers Market

• 22.1. Germany Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Veterinary Biomarkers Market

• 23.1. France Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Veterinary Biomarkers Market

• 24.1. Italy Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Veterinary Biomarkers Market

• 25.1. Spain Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Veterinary Biomarkers Market

• 26.1. Eastern Europe Veterinary Biomarkers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Veterinary Biomarkers Market

• 27.1. Russia Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Veterinary Biomarkers Market

• 28.1. North America Veterinary Biomarkers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Veterinary Biomarkers Market

• 29.1. USA Veterinary Biomarkers Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Veterinary Biomarkers Market

• 30.1. Canada Veterinary Biomarkers Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Veterinary Biomarkers Market

• 31.1. South America Veterinary Biomarkers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Veterinary Biomarkers Market

• 32.1. Brazil Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Veterinary Biomarkers Market

• 33.1. Middle East Veterinary Biomarkers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Veterinary Biomarkers Market

• 34.1. Africa Veterinary Biomarkers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Veterinary Biomarkers Market Regulatory and Investment Landscape

36. Veterinary Biomarkers Market Competitive Landscape And Company Profiles

• 36.1. Veterinary Biomarkers Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Veterinary Biomarkers Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Veterinary Biomarkers Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. IDEXX Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Antech Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Neogen Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Veterinary Biomarkers Market Other Major And Innovative Companies

• Heska Corporation, Olink Proteomics, SomaLogic, Life Diagnostics Inc., INDICAL BIOSCIENCE GmbH, Mercodia AB, Bionote USA Inc., Acuvet Biotech, Alertix Veterinary Diagnostics AB, MI:RNA Diagnostics Ltd., Veterinary Biomarkers Inc., Vetmaya Healthcare Private Limited, VolitionRx, BioVet Diagnostics, Randox Laboratories Ltd.

38. Global Veterinary Biomarkers Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Veterinary Biomarkers Market

40. Veterinary Biomarkers Market High Potential Countries, Segments and Strategies

• 40.1 Veterinary Biomarkers Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Veterinary Biomarkers Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Veterinary Biomarkers Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer